Cance, J. D. http://orcid.org/0000-0002-2797-0037
Adams, E. T.
D’Amico, E. J.
Palimaru, A.
Fernandes, C. S. F.
Fiellin, L. E.
Bonar, E. E.
Walton, M. A.
Komro, K. A.
Knight, D.
Knight, K.
Rao, V.
Youn, S.
Saavedra, L.
Ridenour, T. A.
Deeds, B.
Funding for this research was provided by:
National Institute on Drug Abuse (U24 DA050182, U24 DA050182, U24 DA050182, U24 DA050182, UG3/UH3 DA050235, UG3/UH3 DA050235, UG3/UH3 DA050251, UG3/UH3 DA050251, UG3/UH3 DA050173, UG3/UH3 DA050173, UG3/UH3 DA050234, UG3/UH3 DA050250, UG3/UH3 DA050250, UG3/UH3 DA050252, UG3/UH3 DA050252)
Article History
Accepted: 11 May 2023
First Online: 1 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Fiellin holds equity with Playbl, Inc., a small commercial venture that focuses on the distribution of evidence-based video games for risk reduction and prevention in youth and young adults. This relationship is extensively managed by Dr. Fiellin and her academic institution.